Search Results - "Wenham, R.M"

A phase II, single-dose, open-label study to investigate the safety and efficacy of OTL38 injection for intraoperative imaging of folate receptor-alpha positive ovarian cancer by Randall, L.M, Wenham, R.M, Low, P.S, Dowdy, S.C, Tanyi, J.L

Get full text

Bald and beautiful? Quality of life and chemotherapy-induced alopecia by Clements, M.L, Roscoe, L.A, McClung, C, Wenham, R.M, Shahzad, M.M

Get full text

Gene expression signature based prediction of lymph node metastasis in patients with endometrioid endometrial cancer by Chon, H.S, Kang, S, Lee, J.K, Gonzalez-Bosquet, J, Wenham, R.M, McClung, C, Abdallah, R

Get full text

Histone deacetylase inhibitor MS-275 potentiates cisplatin toxicity in epithelial ovarian cancer by Todd, S.L, George, T, Henry, B, Han, M, Boac, B.M, Ayral, T, Xiong, Y, Marchion, D.C, Magliocco, A, Wenham, R.M

Get full text

Inbound referral patterns for ovarian cancer patients at a National Comprehensive Cancer Network (NCCN) institution by Khulpateea, B.R, Boac, B.M, Xiong, Y, Shahzad, M.M.K, Wenham, R.M, Apte, S.M, Munroe, D.G, Chon, H.S

Get full text

The impact of depression on survival in uterine carcinosarcoma by Bush, S.H, Whynott, R.M, Abdallah, R, Xiong, Y, Chon, H.S, Apte, S.M, Wenham, R.M, Judson, P, Lancaster, J.M, Shahzad, M.M.K

Get full text

Molecular signaling pathways associated with squamous-cell carcinoma of the cervix cisplatin-resistance by Marchion, D, Xiong, Y, Boac, B, Abbasi, F, McClung, C, Judson, P, Apte, S.M, Wenham, R.M, Lancaster, J.M

Get full text

Therapeutic dilemma: Prognostic factors and outcome for patients with neuroendocrine tumors of the cervix by Abdallah, R, Xiong, Y, Bush, S.H, Chon, H.S, Judson Lancaster, P.L, Wenham, R.M, Apte, S.M, Lancaster, J.M, Shahzad, M.M.K

Get full text

Association between endometrioid endometrial cancer (EC) risk classification and gene expression in The Cancer Genome Atlas (TCGA) dataset by Abdallah, R, Lancaster, J.M, Wenham, R.M, Apte, S.M, Judson Lancaster, P.L, Shahzad, M.M.K, Gonzalez-Bosquet, J

Get full text

BCL2 antagonist of cell death (BAD) gene sequence and functional analysis of phosphorylation sites in ovarian cancer by Xiong, Y, Marchion, D, Ramirez, I, Bush, S, Judson Lancaster, P.L, Hakam, A, Wenham, R.M, Apte, S.M, Lancaster, J.M

Get full text

Copy number variation and mutations associated with ovarian cancer chemoresponse by Marchion, D, Judson Lancaster, P.L, Wenham, R.M, Apte, S.M, Lancaster, J.M, Bosquet, J.G

Get full text

The BAD apoptotic pathway: A cervical cancer therapeutic target associated with disease development, therapeutic response and patient survival by Bush, S.H, Marchion, D, Xiong, Y, Abbasi, F, Berry, A, Chon, H.S, Shahzad, M.M.K, Apte, S.M, Wenham, R.M, Judson, P, Lancaster, J.M

Get full text

Development of a rucaparib response signature that shows in vitro predictive value to the PARP inhibitors, ABT-888 and olaparib in ovarian cancer cells by Xiong, Y, Marchion, D, Abbasi, F, Bush, S, Ramirez, I, Bou Zgheib, N, Judson Lancaster, P.L, Wenham, R.M, Lancaster, J.M

Get full text

HSP90 inhibition decreases ovarian cancer cell proliferation and potentiates platinum sensitivity by Marchion, D, Xiong, Y, Bush, S, Al Sawah, E, Al Rubaish, S.S, Ramirez, I, Bou Zgheib, N, Wenham, R.M, Lancaster, J.M

Get full text

352 Final Results of the First in Man Trial of MK4827, a Poly (ADP-ribose) Polymerase (PARP) Inhibitor with Antitumor Activity in BRCA Carriers and Sporadic Cancer Patients by Sandhu, S.K, Wilding, G, Schelman, W.R, Omlin, A, Kreischer, N, Carpenter, C, Iannone, R, Kaye, S, de-Bono, J.S, Wenham, R.M

Get full text

362 First in human trial of a poly(ADP)-ribose polymerase (PARP) inhibitor MK-4827 in advanced cancer patients (p) with antitumor activity in BRCA-deficient and sporadic ovarian cancers by Wenham, R.M, Sandhu, S.K, Wilding, G, Sun, L, Toniatti, C, Stroh, M, Carpenter, C, de-Bono, J, Baird, R, Schelman, W.R

Get full text

Predictive value of CIRS severity index on survival in elderly women (>= 70 years) with advanced epithelial ovarian cancer by Song, Y.J., Todd, S.L., Xiong, Y., Wenham, R.M., Extermann, M., Chon, H.S.

Get full text

Atezolizumab and Stereotactic Body Radiation Therapy in Metastatic, Recurrent or Persistent Cervical Cancer: Interim Results from a Non-Randomized, Open-Label Phase II Multi-Institutional Study by Ahmed, K.A., Quick, A.M., Bixel, K., Kim, Y., Lemerond, E., Chon, H.S., Chern, J.Y., Fernandez, D.C., Hoffman, M.S., Kim, S., Lam, C., Montejo, M.E., Shahzad, M.M., Wenham, R.M.

Get full text

A phase Ib study of navicixizumab and weekly paclitaxel in heavily pretreated platinum resistant ovarian, primary peritoneal or fallopian tube cancer by Fu, S., Burger, R.A., Hamilton, E., Corr, B.R., Naumann, R.W., Wenham, R.M., Morgan, M.A., Stagg, R., Moore, K.N.

Get full text

Utilizing the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated with Adjuvant Radiotherapy by Prince, A., Mohammadi, H., Fernandez, D.C., Montejo, M.E., Chon, H.S., Wenham, R.M., Eschrich, S.A., Torres-Roca, J.F., Ahmed, K.A.

Get full text